These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7128980)

  • 21. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electrocardiographic and radiologic evaluation in cardiac involvement in patients with beta-thalassemia major].
    Lo Jacono F; Agnello D; Malizia R; Maltese I; Marasa' R
    Pediatria (Napoli); 1980 Sep; 88(3):385-93. PubMed ID: 7220158
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of cardiac function in patients with thalassemia major.
    Nienhuis AW; Griffith P; Strawczynski H; Henry W; Borer J; Leon M; Anderson WF
    Ann N Y Acad Sci; 1980; 344():384-96. PubMed ID: 6930878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 26. Early iron chelation therapy in thalassemia major.
    Russo G; Romeo MA; Musumeci S; Schilirò G; Di Gregorio F
    Haematologica; 1983; 68(1):69-73. PubMed ID: 6404710
    [No Abstract]   [Full Text] [Related]  

  • 27. [Monitoring of the harmful effects of iron on the hearts of patients with beta-thalassemia major, using non-invasive cardiological technics].
    Pisano GF; Binaghi F; Putzu ML; Bragotti R; Manconi E; Urgu G; Pitzus F
    Boll Soc Ital Cardiol; 1981; 26(10):1227-33. PubMed ID: 7349145
    [No Abstract]   [Full Text] [Related]  

  • 28. Intensive long-term intravenous iron-chelation therapy with deferoxamine in thalassemic patients.
    Cianciulli P; Forte L; Sorrentino F; Palombi M; Papa G; Marciani MG
    Bone Marrow Transplant; 1993; 12 Suppl 1():5-8. PubMed ID: 8374563
    [No Abstract]   [Full Text] [Related]  

  • 29. Subcutaneous diethylene triamine pentaacetic acid: comparison with desferrioxamine in thalassemic patients with iron overload.
    Pippard MJ; Jackson MJ; Modell CB
    Birth Defects Orig Artic Ser; 1988; 23(5B):105-9. PubMed ID: 3390531
    [No Abstract]   [Full Text] [Related]  

  • 30. Beta thalassemia and heart disease: three decades of gradual progress.
    Engle MA; Ehlers KH; O'Loughlin JE; Giardina PJ; Hilgartner MW
    Trans Am Clin Climatol Assoc; 1985; 96():24-33. PubMed ID: 6242259
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biochemical data in the phosphate depletion syndrome of thalassemic patient (author's transl)].
    Bianchi C; Carcano G; Pradella C; Proverbio MC; Weber G; Mazzucchelli M; Masera G; Terzoli S
    Pediatr Med Chir; 1981; 3(1):15-21. PubMed ID: 7301615
    [No Abstract]   [Full Text] [Related]  

  • 32. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
    Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract]   [Full Text] [Related]  

  • 33. [Severe cardiomyopathy in a woman with intermediate beta-thalassemia. Regression of cardiac failure with desferrioxamine].
    Mancuso L; Iacona MA; Marchi S; Rigano P; Geraci E
    G Ital Cardiol; 1985 Sep; 15(9):916-20. PubMed ID: 4085735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac study by dobutamine stress echocardiography in thalassemic patients.
    Mariotti E; Agostini A; Angelucci E; Cesaroni P; Lucarelli G; Sgarbi E
    Bone Marrow Transplant; 1993; 12 Suppl 1():14-5. PubMed ID: 8374553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation of transferrin saturation and ferritin in non-splenectomized thalassemic children.
    Wangruangsathit S; Hathirat P; Chuansumrit A; Pakakasama S; Hongeng S
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S74-6. PubMed ID: 10730522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The echocardiographic evaluation of multiply transfused thalassemia patients over the age of 10].
    De Martino MP; Multari EI; Costantino D; Mammì F; Iannopollo M; Costantino G
    Pediatr Med Chir; 1990; 12(4):365-9. PubMed ID: 2075101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Echocardiographic studies in evaluation of the hemodynamic stages of hypertensive cardiopathy].
    Varricchio M; Russo R; Cacciapuoti F; D'Angelo G; Verza M; Gentile S
    Boll Soc Ital Cardiol; 1978; 23(7):1192-201. PubMed ID: 549614
    [No Abstract]   [Full Text] [Related]  

  • 38. Scoliosis in beta thalassemia.
    Papageorgiou O; Papanastasiou DA; Beratis NG; Korovessis P; Oikonomopoulos A
    Pediatrics; 1991 Aug; 88(2):341-5. PubMed ID: 1861937
    [No Abstract]   [Full Text] [Related]  

  • 39. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
    Pakbaz Z; Fischer R; Treadwell M; Yamashita R; Fung EB; Calvelli L; Quirolo K; Foote D; Harmatz P; Vichinsky EP
    Ann N Y Acad Sci; 2005; 1054():486-91. PubMed ID: 16339703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.